קונבריזה

Țară: Israel

Limbă: ebraică

Sursă: Ministry of Health

Ingredient activ:

BAZEDOXIFENE AS ACETATE 20 MG

Disponibil de la:

NEOPHARM LTD

Codul ATC:

G03XC02

Forma farmaceutică:

COATED TABLETS

Calea de administrare:

PER OS

Produs de:

PFIZER IRELAND PHARMACEUTICALS

Grupul Terapeutică:

BAZEDOXIFENE

Indicații terapeutice:

CONBRIZA is indicated for the treatment of postmenopausal osteoporosis in women at increased risk of fracture. A significant reduction in the incidence of vertebral fractures has been demonstrated; efficacy on hip fractures has not been established. When determining the choice of CONBRIZA or other therapies, including oestrogens, for an individual postmenopausal woman, consideration should be given to menopausal symptoms, effects on uterine and breast tissues, and cardiovascular risks and benefit

Data de autorizare:

2013-04-01